Keros Therapeutics, Inc. (KROS): SCHEDULE 13G filed Feb 14, 2025

Form type

SCHEDULE 13G

Filing date

Feb 14, 2025

Accession number

0000902664-25-001043

Filer

Keros Therapeutics, Inc. (CIK 1664710)